R. Gutiérrez-Aguilar

R. Gutiérrez-Aguilar

Auto-generated profile, based on publicly available information

R. Gutiérrez-Aguilar

Department of Gastroenterology, National Medical Center of the West, Mexican Institute of Social Security, Guadalajara, Jalisco, Mexico

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Brazilian Journal of Medical and Biological Research
Verified
Journal Article
Open access
PDF file
KVKatia Carolina Vázquez
Katia Carolina Vázquez
ABA.R. Bustos-Carpinteyro
A.R. Bustos-Carpinteyro
AGA. García-Ruvalcaba
A. García-Ruvalcaba
MMMaría Teresa Magaña-Torres
María Teresa Magaña-Torres
RGR. Gutiérrez-Aguilar
R. Gutiérrez-Aguilar
Josefina Yoaly Sánchez LópezJosefina Yoaly Sánchez López
Josefina Yoaly Sánchez López
Gastric cancer (GC) is the third most lethal type of cancer worldwide. Single nucleotide polymorphisms (SNPs) in regulatory sites or coding regions can modify the expression of genes involved in gastric carcinogenesis, as ERBB2, which encodes for the tyrosine-kinase receptor HER-2. The aim of this work was to analyze the association of the polymorphisms: rs2643194, rs2517951, rs2643195, rs2934971, and rs1058808 with GC, as they have not yet been analyzed in GC patients, as well as to report their frequency in the general Mexican population (GMP). We studied genomic DNA from subjects with GC (n=74), gastric inflammatory diseases (GID, n=76 control subjects), and GMP (n=102). Genotypes were obtained by means of real-time PCR and DNA-sequencing. The risks for GC were estimated through odds ratio (OR) using the Cochran-Armitage trend test and multinomial logistic regression. Increased risk for GC was observed under the dominant inheritance model for the rs2643194 TT or CT genotypes with an OR of 2.75 (95%CI 1.12−6.75, P=0.023); the rs2934971 TT or GT genotypes with an OR of 2.41 (95%CI 1.01−5.76, P=0.043), and the rs1058808 GG or CG genotypes with an OR of 2.21 (95%CI 1.00−4.87, P=0.046). The SNPs rs2643194, rs2934971, and rs1058808 of the ERBB2 gene were associated with increased risk for GC.